KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 81 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,786 | -41.7% | 14,644 | -12.4% | 0.00% | -50.0% |
| Q1 2024 | $15,077 | -63.8% | 16,723 | -62.0% | 0.00% | -77.8% |
| Q4 2023 | $41,704 | -51.1% | 44,019 | -38.6% | 0.01% | -40.0% |
| Q3 2023 | $85,296 | -63.2% | 71,677 | -24.3% | 0.02% | -64.3% |
| Q2 2023 | $231,875 | +46.8% | 94,643 | +417.3% | 0.04% | +7.7% |
| Q3 2022 | $158,000 | – | 18,297 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |